TOP1 expression was independently associated with BRCA1/2-related breast carcinomas (adjusted odds ratio [OR] 3.75; 95% confidence interval [95% CI], 1.82–7.71, p < 0.001). This evidence concerns the gene BRCA1 and breast carcinoma.